Femasys (FEMY) announced the introduction of its FemSperm Setup Kit, the first in a planned family of products designed to fully enable gynecologists for FemaSeed Intratubal Insemination. The setup kit includes customized components, such as a pre-configured centrifuge to optimize sperm preparation for use with FemaSeed. “Our FemSperm Setup Kit represents the beginning of a broader family of products designed to fully activate gynecologists to adopt and expand FemaSeed use,” said Kathy Lee-Sepsick, Chief Executive Officer and Founder of Femasys Inc. “This strategic step strengthens our commercialization pathway by bringing FemaSeed into the hands of the physicians who see patients first, opening new access points for women seeking fertility care and positioning Femasys for scalable revenue growth.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys Gains UK Approval for FemBloc Birth Control
- Femasys secures U.K. Regulatory Approval of FemBloc permanent birth control
- Femasys files to sell 11.43M shares of common stock
- Optimistic Buy Rating for Femasys Driven by Strategic Initiatives and Product Innovations
- Femasys reports Q2 EPS (16c) vs. (21c) last year